Cite
Intravitreal Fluocinolone Acetonide Implant (FAc, 0.19 mg, ILUVIEN®) in the Treatment of Patients with Recurrent Cystoid Macular Edema After Pars Plana Vitrectomy.
MLA
Lima-Fontes, Mário, et al. “Intravitreal Fluocinolone Acetonide Implant (FAc, 0.19 Mg, ILUVIEN®) in the Treatment of Patients with Recurrent Cystoid Macular Edema After Pars Plana Vitrectomy.” Ophthalmology & Therapy, vol. 12, no. 1, Feb. 2023, pp. 377–88. EBSCOhost, https://doi.org/10.1007/s40123-022-00613-9.
APA
Lima-Fontes, M., Leuzinger-Dias, M., Barros-Pereira, R., Fernandes, V., Falcão, M., Falcão-Reis, F., Rocha-Sousa, A., & Alves-Faria, P. (2023). Intravitreal Fluocinolone Acetonide Implant (FAc, 0.19 mg, ILUVIEN®) in the Treatment of Patients with Recurrent Cystoid Macular Edema After Pars Plana Vitrectomy. Ophthalmology & Therapy, 12(1), 377–388. https://doi.org/10.1007/s40123-022-00613-9
Chicago
Lima-Fontes, Mário, Mariana Leuzinger-Dias, Ricardo Barros-Pereira, Vítor Fernandes, Manuel Falcão, Fernando Falcão-Reis, Amândio Rocha-Sousa, and Pedro Alves-Faria. 2023. “Intravitreal Fluocinolone Acetonide Implant (FAc, 0.19 Mg, ILUVIEN®) in the Treatment of Patients with Recurrent Cystoid Macular Edema After Pars Plana Vitrectomy.” Ophthalmology & Therapy 12 (1): 377–88. doi:10.1007/s40123-022-00613-9.